SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-184702
Filing Date
2023-07-10
Accepted
2023-07-10 16:41:00
Documents
13
Period of Report
2023-07-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d527457d8k.htm   iXBRL 8-K 24940
2 EX-99.1 d527457dex991.htm EX-99.1 11492
  Complete submission text file 0001193125-23-184702.txt   166954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA maia-20230710.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230710_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230710_pre.xml EX-101.PRE 11728
7 EXTRACTED XBRL INSTANCE DOCUMENT d527457d8k_htm.xml XML 3445
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 231080224
SIC: 2834 Pharmaceutical Preparations